1. Antineoplastics
   , 2017, Reactions Weekly CrossRef
2. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy
   Xiujuan Xu et al, 2019, Radiat Oncol CrossRef
3. Assessing Outcomes of Patients Treated With Re-Irradiation Utilizing Proton Pencil-Beam Scanning for Primary or Recurrent Malignancies of the Esophagus and Gastroesophageal Junction
   Cristina M. DeCesaris et al, 2020, Journal of Thoracic Oncology CrossRef
4. Definitive re‑irradiation of locally recurrent esophageal cancer after trimodality therapy in patients with a poor performance status
   Daniel Kim et al, 2020, mol clin onc CrossRef
5. Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis
   Kaikai Zhao et al, 2020, Radiat Oncol CrossRef
6. Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
   Koichi Yagi et al, 2021, Ann Gastroenterol Surg CrossRef
7. A re-irradiation dose of 55–60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy
   Xun Wu et al, 2021, Radiat Oncol CrossRef
8. Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees
   Michael D. Chuong et al, 2021, Front. Oncol. CrossRef
9. Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site
   Xinran Wang et al, 2022, BMC Cancer CrossRef
10. Three-hole oesophagectomy following bilateral lung transplant for cystic fibrosis
    Roy Avraham Hilzenrat et al, 2022, BMJ Case Rep CrossRef
11. Re-irradiation for intra-thoracic tumours and extra-thoracic breast cancer: dose accumulation, evaluation of efficacy and toxicity based on a literature review
    Dorota Gabrys et al, 2022, BJR CrossRef
12. Efficacy and safety of re-irradiation for locoregional esophageal squamous cell carcinoma recurrence after radiotherapy: a systematic review and meta-analysis
    Kuntian Lan et al, 2022, Radiat Oncol CrossRef
13. Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study
    Yuzhong Cui et al, 2022, Clin Transl Oncol CrossRef
14. Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT
    Geng Xiang et al, 2023, Radiat Oncol CrossRef